Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal

Guilherme Gonçalves, João Frade, Carla Nunes, João Rodrigo Mesquita, Maria São José Nascimento

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

In populations vaccinated with two doses of combined measles-mumps-rubella vaccine (MMR), the serum levels of antibodies against measles depend on the vaccination schedule, time elapsed from the last dose and the area-specific epidemiological situation. Variables measuring "schedule" are age at first and second doses of MMR and intervals derived from that. Changes in vaccination schedules have been made in Portugal. The specific objectives of this study were to measure the association between those potential determinants and the concentration of measles-specific IgG antibodies, after the second dose of MMR. Convenience samples of three Portuguese birth cohorts were selected for this study (41, 66 and 60 born, respectively, in 2001-2003, 1990-1993 and 1994-1995). Geometric mean concentrations (GMC) for measles IgG were, respectively, 934, 251 and 144. mIU/ml; p

Original languageEnglish
Pages (from-to)5057-5063
Number of pages7
JournalVaccine
Volume33
Issue number39
DOIs
Publication statusPublished - 22 Sep 2015

Fingerprint

Measles-Mumps-Rubella Vaccine
Portugal
Measles
Appointments and Schedules
Vaccines
vaccines
antibodies
Antibodies
Vaccination
dosage
Immunoglobulin G
Combined Vaccines
vaccination
Parturition
Serum
Population
sampling

Keywords

  • Antibodies
  • Immunisation
  • Measles
  • Measles-mumps-rubella (MMR) vaccine
  • Vaccination schedule

Cite this

Gonçalves, Guilherme ; Frade, João ; Nunes, Carla ; Mesquita, João Rodrigo ; Nascimento, Maria São José. / Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal. In: Vaccine. 2015 ; Vol. 33, No. 39. pp. 5057-5063.
@article{5fb43afca3fe4b1381ce2e93dd7d30de,
title = "Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal",
abstract = "In populations vaccinated with two doses of combined measles-mumps-rubella vaccine (MMR), the serum levels of antibodies against measles depend on the vaccination schedule, time elapsed from the last dose and the area-specific epidemiological situation. Variables measuring {"}schedule{"} are age at first and second doses of MMR and intervals derived from that. Changes in vaccination schedules have been made in Portugal. The specific objectives of this study were to measure the association between those potential determinants and the concentration of measles-specific IgG antibodies, after the second dose of MMR. Convenience samples of three Portuguese birth cohorts were selected for this study (41, 66 and 60 born, respectively, in 2001-2003, 1990-1993 and 1994-1995). Geometric mean concentrations (GMC) for measles IgG were, respectively, 934, 251 and 144. mIU/ml; p",
keywords = "Antibodies, Immunisation, Measles, Measles-mumps-rubella (MMR) vaccine, Vaccination schedule",
author = "Guilherme Gon{\cc}alves and Jo{\~a}o Frade and Carla Nunes and Mesquita, {Jo{\~a}o Rodrigo} and Nascimento, {Maria S{\~a}o Jos{\'e}}",
note = "PMID: 26319061 Scopus: 84941739145 WOS: 000361862900006",
year = "2015",
month = "9",
day = "22",
doi = "10.1016/j.vaccine.2015.08.057",
language = "English",
volume = "33",
pages = "5057--5063",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier Science B.V., Amsterdam.",
number = "39",

}

Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal. / Gonçalves, Guilherme; Frade, João; Nunes, Carla; Mesquita, João Rodrigo; Nascimento, Maria São José.

In: Vaccine, Vol. 33, No. 39, 22.09.2015, p. 5057-5063.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Persistence of measles antibodies, following changes in the recommended age for the second dose of MMR-vaccine in Portugal

AU - Gonçalves, Guilherme

AU - Frade, João

AU - Nunes, Carla

AU - Mesquita, João Rodrigo

AU - Nascimento, Maria São José

N1 - PMID: 26319061 Scopus: 84941739145 WOS: 000361862900006

PY - 2015/9/22

Y1 - 2015/9/22

N2 - In populations vaccinated with two doses of combined measles-mumps-rubella vaccine (MMR), the serum levels of antibodies against measles depend on the vaccination schedule, time elapsed from the last dose and the area-specific epidemiological situation. Variables measuring "schedule" are age at first and second doses of MMR and intervals derived from that. Changes in vaccination schedules have been made in Portugal. The specific objectives of this study were to measure the association between those potential determinants and the concentration of measles-specific IgG antibodies, after the second dose of MMR. Convenience samples of three Portuguese birth cohorts were selected for this study (41, 66 and 60 born, respectively, in 2001-2003, 1990-1993 and 1994-1995). Geometric mean concentrations (GMC) for measles IgG were, respectively, 934, 251 and 144. mIU/ml; p

AB - In populations vaccinated with two doses of combined measles-mumps-rubella vaccine (MMR), the serum levels of antibodies against measles depend on the vaccination schedule, time elapsed from the last dose and the area-specific epidemiological situation. Variables measuring "schedule" are age at first and second doses of MMR and intervals derived from that. Changes in vaccination schedules have been made in Portugal. The specific objectives of this study were to measure the association between those potential determinants and the concentration of measles-specific IgG antibodies, after the second dose of MMR. Convenience samples of three Portuguese birth cohorts were selected for this study (41, 66 and 60 born, respectively, in 2001-2003, 1990-1993 and 1994-1995). Geometric mean concentrations (GMC) for measles IgG were, respectively, 934, 251 and 144. mIU/ml; p

KW - Antibodies

KW - Immunisation

KW - Measles

KW - Measles-mumps-rubella (MMR) vaccine

KW - Vaccination schedule

UR - http://www.scopus.com/inward/record.url?scp=84941739145&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.08.057

DO - 10.1016/j.vaccine.2015.08.057

M3 - Article

VL - 33

SP - 5057

EP - 5063

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 39

ER -